Higher Repeated THC Doses Expanded Some Brain Adaptations but Left Other Regions Unchanged
Repeated THC exposure did not alter every brain region equally in a mouse study. Higher escalating-dose regimens produced broader changes in receptor function, while some regions showed no measured change.
The study linked dosing and several outcomes
Mice received a fixed repeated THC dose or escalating schedules. Researchers tested movement, immobility, antinociception and temperature, then examined cannabinoid-stimulated G-protein activity and receptor binding in brain tissue.
The regional pattern depended on exposure
The abstract reports functional reductions in several regions after all active regimens. Other regions showed reductions only after the highest escalating schedule. No change in the measured functional assay was found in the globus pallidus or entopeduncular nucleus under any treatment.
Behavior and receptor assays are related but distinct
The lower repeated dose produced less behavioral tolerance, with the amount depending on the task. Receptor-binding changes also varied by region and dose. One region's result therefore cannot represent the entire brain.
Escalating-dose animal treatment does not reproduce every pattern of human cannabis consumption. The absence of a measured change in one region does not establish absence of all drug effects there, and a receptor change elsewhere is not automatically injury. These findings support dose- and circuit-specific adaptation rather than a single global tolerance state.
Related: interpreting cannabis tolerance claims.
Research cited
McKinney DL; Cassidy MP; Collier LM; Martin BR; Wiley JL; Selley DE; Sim-Selley LJ. Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol. The Journal of pharmacology and experimental therapeutics (2008). doi:10.1124/jpet.107.130328. Findings discussed from the study abstract.
